These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 209591)

  • 41. Serum protein electrophoresis in healthy subjects and patients with liver disease.
    Zuberi SJ; Lodi TZ
    J Pak Med Assoc; 1978 Oct; 28(10):140-1. PubMed ID: 101684
    [No Abstract]   [Full Text] [Related]  

  • 42. Grading of severity of the condition in burn patients by serum protein and albumin/globulin studies.
    Kumar P
    Ann Plast Surg; 2010 Jul; 65(1):74-9. PubMed ID: 20548219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection and determination of alpha-feto-protein in human serum. Use in hepato-gastroenterology].
    Borel-Giraud N; Berthet P; Nyssen M; Dorche J; Girard M; Bel A; Vachon A; Plauchu A; Saint Cyr M
    Nouv Presse Med; 1975 Jan; 4(1):27-30. PubMed ID: 49879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of alpha 1-antitrypsin and alpha-2 macroglobulin in hepatopathies].
    Triolo L; Mian G; Magris D; Novello E; D'Agnolo B
    Minerva Med; 1979 Feb; 70(8):605-10. PubMed ID: 86175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
    Eleftheriou N; Heathcote J; Thomas HC; Sherlock S
    J Clin Pathol; 1977 Aug; 30(8):704-8. PubMed ID: 74380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical evaluation of serum levels of tryptophan in hepatobiliary disease.
    Yoshida K; Hirayama C
    Clin Chim Acta; 1980 Feb; 101(2-3):235-40. PubMed ID: 6244122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma endothelin-1 concentrations are elevated in acute hepatitis and liver cirrhosis but not in chronic hepatitis.
    Uchida Y; Watanabe M
    Gastroenterol Jpn; 1993 Oct; 28(5):666-72. PubMed ID: 8224617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serum TBG value in chronic liver diseases and hepatoma with special referrence to microheterogeneity of TBG (author's transl)].
    Miyazaki J; Tanaka N; Iino S; Endo Y
    Horumon To Rinsho; 1982 Feb; 30(2):145-7. PubMed ID: 6177454
    [No Abstract]   [Full Text] [Related]  

  • 49. [Alpha-fetoprotein. Part II].
    Delpré G; Gilat T
    Gastroenterol Clin Biol; 1978 Feb; 2(2):193-214. PubMed ID: 76586
    [No Abstract]   [Full Text] [Related]  

  • 50. Incidence of paraproteins in chronic liver diseases.
    Englisová M; Englis M; Hoenig V; Hoenigová J
    Scand J Gastroenterol; 1968; 3(4):413-6. PubMed ID: 4179183
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum tenascin levels in chronic liver disease.
    Yamauchi M; Mizuhara Y; Maezawa Y; Toda G
    Liver; 1994 Jun; 14(3):148-53. PubMed ID: 7521506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in blood selenium level and glutathione peroxidase activity and their clinical significance in primary liver cancer and benign liver diseases].
    Yang DH; Liu WW; Yuan AL
    Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):612-4, 652. PubMed ID: 2852581
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.
    Murawaki Y; Yamamoto H; Kawasaki H; Shima H
    Clin Chim Acta; 1993 Sep; 218(1):47-58. PubMed ID: 8299219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand.
    Pramoolsinsap C; Promvanit N; Komindr S; Lerdverasirikul P; Srianujata S
    J Gastroenterol; 1994 Oct; 29(5):610-5. PubMed ID: 8000510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced serum somatomedin activity in patients with chronic liver disease.
    Wu A; Grant DB; Hambley J; Levi AJ
    Clin Sci Mol Med; 1974 Oct; 47(4):359-66. PubMed ID: 4154157
    [No Abstract]   [Full Text] [Related]  

  • 56. Predictive value of serum sex hormone binding globulin for the occurrence of hepatocellular carcinoma in male patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Uzzan B; Pateron D; Trinchet JC; Perret G; Beaugrand M
    J Hepatol; 1997 Jan; 26(1):96-102. PubMed ID: 9148029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Group-specific component [Gc] levels in chronic liver disease.
    Mihas AA; Hirschowitz BI
    J Med; 1978; 9(2):109-15. PubMed ID: 78953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Foetoglobin and primary liver cancer.
    Smith JB; Todd D
    Lancet; 1968 Oct; 2(7572):833. PubMed ID: 4175629
    [No Abstract]   [Full Text] [Related]  

  • 59. Elevation of serum cystatin C concentrations in patients with chronic liver disease.
    Takeuchi M; Fukuda Y; Nakano I; Katano Y; Hayakawa T
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):951-5. PubMed ID: 11507361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrinolytic activity of blood in hepatic disorders.
    Varma SB; Misra NP
    Indian J Med Sci; 1973 May; 27(5):384-7. PubMed ID: 4746239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.